Leukemia SPOREs
While major advances in leukemia diagnosis and treatment were achieved in the last 50 years, especially in childhood leukemia, this group of diseases remains a very serious medical problem. According to the NCI's Surveillance, Epidemiology, and End Results Program (SEER) statistical data, it is estimated that in 2024 there will be a total of 62,770 new cases of leukemia in the U.S., and that 23,670 people will die of this disease. In 2017-2021, the average annual incidence rate of leukemia in the United States was 14.1 per 100,000, and the average annual observed death rate was 5.9 per 100,000 based on years 2018-2022. The first round of SPORE applications in leukemia took place in 2002, with the subsequent award of the first Leukemia SPORE in 2003.